Publications by authors named "Alberto Risueño"

12Publications

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.

J Clin Oncol 2016 09 27;34(25):2988-96. Epub 2016 Jun 27.

Valeria Santini, University of Florence, Florence, Italy; Antonio Almeida, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal; Aristoteles Giagounidis and Stefanie Gröpper, Marien Hospital Düsseldorf; Norbert Gattermann, Heinrich-Heine-Universität, Düsseldorf; Uwe Platzbecker, Technical University Dresden, Dresden, Germany; Anna Jonasova, Charles University General Hospital, Prague, Czech Republic; Norbert Vey, Centre Régional de Lutte Contre le Cancer, Marseille; Pierre Fenaux, Université Paris, Paris, France; Francis Séguy and Albert Hoenekopp, Celgene International, Boudry, Switzerland; Ghulam J. Mufti, King's College Hospital, London, United Kingdom; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Moshe Mittelman and Ron Ram, Tel Aviv University; Ofer Shpilberg, Assuta Medical Center, Tel Aviv, Israel; Consuelo del Cañizo, Hospital Universitario de Salamanca, Salamanca; Alberto Risueño, Celgene Institute for Translational Research Europe, Seville, Spain; Keiya Ozawa, The University of Tokyo, Tokyo, Japan; Kyle J. MacBeth, Celgene Corporation, San Francisco, CA; and Jianhua Zhong and C.L. Beach, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0118DOI Listing
September 2016

A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples.

BMC Genomics 2014 Oct 8;15:879. Epub 2014 Oct 8.

Bioinformatics and Functional Genomics Research Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL/IBSAL), Salamanca 37007, Spain.

View Article

Download full-text PDF

Source
http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2
Publisher Site
http://dx.doi.org/10.1186/1471-2164-15-879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298068PMC
October 2014

TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations.

Biomed Res Int 2014 18;2014:814294. Epub 2014 Feb 18.

IBSAL, IBMCC, Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain ; Servicio de Hematología y Departamento de Medicina, Hospital Clínico Universitario de Salamanca, Paseo San Vicente 58, 37007 Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/814294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947698PMC
May 2015

GATExplorer: genomic and transcriptomic explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs.

BMC Bioinformatics 2010 Apr 29;11:221. Epub 2010 Apr 29.

Bioinformatics and Functional Genomics Research Group, Cancer Research Center (CiC-IBMCC, CSIC/USAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-11-221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875241PMC
April 2010

Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles.

PLoS One 2008 15;3(12):e3911. Epub 2008 Dec 15.

Bioinformatics and Functional Genomics Research Group, Cancer Research Center (CIC-IBMCC, CSIC/USAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003911PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597745PMC
February 2009